Neutralizing Efficacy of Encapsulin Nanoparticles against SARS-CoV2 Variants of Concern
Rapid emergence of the SARS-CoV-2 variants has dampened the protective efficacy of existing authorized vaccines. Nanoparticle platforms offer a means to improve vaccine immunogenicity by presenting multiple copies of desired antigens in a repetitive manner which closely mimics natural infection. We...
Main Authors: | Sara Khaleeq, Nayanika Sengupta, Sahil Kumar, Unnatiben Rajeshbhai Patel, Raju S. Rajmani, Poorvi Reddy, Suman Pandey, Randhir Singh, Somnath Dutta, Rajesh P. Ringe, Raghavan Varadarajan |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-01-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/15/2/346 |
Similar Items
-
Modulating the Viscoelastic Properties of Covalently Crosslinked Protein Hydrogels
by: Rossana Boni, et al.
Published: (2023-06-01) -
A modular and self-adjuvanted multivalent vaccine platform based on porcine circovirus virus-like nanoparticles
by: Ze-Hui Liu, et al.
Published: (2022-11-01) -
Cellular synthesis of protein pretzelanes
by: Xilin Bai, et al.
Published: (2022-06-01) -
Nanoparticle vaccines based on the receptor binding domain of porcine deltacoronavirus elicit robust protective immune responses in mice
by: Yuanhong Wang, et al.
Published: (2024-03-01) -
Fiber manipulation and post-assembly nanobody conjugation for adenoviral vector retargeting through SpyTag-SpyCatcher protein ligation
by: Maryam Kadkhodazadeh, et al.
Published: (2022-12-01)